Brief: Zynerba Pharmaceuticals Enters Into Equity Purchase Agreement For Up To $20 Million With Lincoln Park Capital
July 21 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS ENTERS INTO EQUITY PURCHASE
AGREEMENT FOR UP TO $20 MILLION WITH LINCOLN PARK CAPITAL
* ZYNERBA PHARMACEUTICALS - CO TO HAVE RIGHT TO SELL TO LPC
UP TO
$20 MILLION WORTH OF SHARES OVER 36-MONTH TERM OF AGREEMENT
Source text for Eikon: ID:nGNX8dZyJQ
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary